The assay should have the following attributes: 1) distinguish between normal and haemophilia dogs, 2) monitor correlation between plasma FVIII/FIX in vitro activity and thrombin generation and 3) assess for correlation between FVIII activity and thrombin generation in ex vivo samples. The gene discussed is F8; the disease is hemophilia.